Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Maintaining HIPAA-compliant documentation practices across the full encounter record also protects the practice in the event of a payer audit on medical necessity
Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities
Actin regulation muscle satellite cells, fibroblasts, keratinocytes, and endothelial cells are mobilized to the area to be repaired
Supplied as a lyophilised powder, third-party HPLC-verified to greater than 99% purity
AOD9604, a peptide fragment, is studied in metabolic research
Pros: Extended half-life compared to unmodified MGF, in theory allowing fewer, more practical dosing intervals Mechanism aligns with well-studied endogenous muscle-repair biology (satellite cell activation, IGF-1 pathway) Widely available from research-chemical vendors for lab/research purposes Cons: No FDA approval, no completed human clinical trials, and no regulator-reviewed safety or efficacy data Prohibited in competitive sport under WADA growth-factor rules Product quality and purity vary significantly between unregulated research-chemical suppliers Side Effects: Not well characterized due to the absence of an approved label
